Old Web
English
Sign In
Acemap
>
authorDetail
>
Elizabeth Pae
Elizabeth Pae
University of Arizona
Cancer research
non-small cell lung cancer (NSCLC)
Alectinib
Pathology
Crizotinib
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Economic evaluation of anaplastic lymphoma kinase (ALK) inhibitors brigatinib, alectinib and crizotinib in non-small cell lung cancer (NSCLC): Analysis for intracranial metastasis-related progression free survival (CNSPFS).
2019
Journal of Clinical Oncology
Nimer S. Alkhatib
Briana Choi
Elizabeth Pae
Hani M. Babiker
Linda L. Garland
Alyssa Henglefelt
Ali McBride
Ivo Abraham
Show All
Source
Cite
Save
Citations (0)
Economic evaluation crizotinib, alectinib and brigatinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC).
2019
Journal of Clinical Oncology
Briana Choi
Nimer S. Alkhatib
Elizabeth Pae
Hani M. Babiker
Linda L. Garland
Alyssa Henglefelt
Ali McBride
Ivo Abraham
Show All
Source
Cite
Save
Citations (1)
1